Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Dexcom Inc.

Headquarters: San Diego, CA, United States of America
Year Founded: 1999
Status: Public
Industry Sector: HealthTechnology
CEO: Kevin Ronald Sayer, CPA
Number Of Employees: 10,300
Enterprise Value: $32,103,679,000
PE Ratio: 48.07
Exchange/Ticker 1: NASDAQ:DXCM
Exchange/Ticker 2: N/A
Latest Market Cap: $26,760,067,072

BioCentury | Sep 1, 2022
Management Tracks

Demuth to lead R&D at MorphoSys as Peters retires

Plus new CFO, CBO, general counsel at Revolution, and updates from Photocure, Nature’s Toolbox, Ginkgo and more
BioCentury | Sep 11, 2021
Management Tracks

New CEO for Eden following conviction of JHL execs

Plus: Mavilio, Loggia join Orchard and updates from PMV, Verseau, Apexigen, VectivBio, Protagonist and more
BioCentury | Feb 16, 2019
Product Development

Embedding digital in Lilly’s portfolio

How Lilly is using digital technologies to improve patient outcomes
BioCentury | Sep 12, 2016
Regulation

Adding to A1c

How the diabetes community is improving, linking outcomes to glucose levels
BioCentury | Aug 8, 2016
Product Development

Galvanizing bioelectronics

How Galvani plans to push forward on all fronts in bioelectronics
BioCentury | Sep 1, 2015
Company News

Sanofi, Google in diabetes deal

BioCentury | Nov 14, 2011
Company News

DexCom, Roche deal

BioCentury | Jun 25, 2007
Company News

Vasogen management update

Items per page:
1 - 8 of 8